Pei-Jun Liu (Peijun Liu, Juan Li, P Li)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 27

Top Topics

Breast Cancer Cells

Dna Methylation

Endoplasmic Reticulum Stress

Top Venues

Biomarkers in medicine

Clinical and experimental pharmacology & physiology

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Juan Li, Can Zhou, Xiaoqian Gao, Tan Tan, Miao Zhang, Yazhao Li, He Chen, Ruiqi Wang, Bo Wang, Jie Liu, Pei-Jun Liu
S100A10 promotes cancer metastasis via recruitment of MDSCs within the lungs. Oncoimmunology 13 (1) (2024)
Juan Li, Can Zhou, Xiaoqian Gao, Tan Tan, Miao Zhang, Yazhao Li, He Chen, Ruiqi Wang, Bo Wang, Jie Liu, Pei-Jun Liu
S100A10 promotes cancer metastasis via recruitment of MDSCs within the lungs. Oncoimmunology 13 (1) (2024)
Juan Li, Can Zhou, Xiaoqian Gao, Tan Tan, Miao Zhang, Yazhao Li, He Chen, Ruiqi Wang, Bo Wang, Jie Liu, Pei-Jun Liu
S100A10 promotes cancer metastasis via recruitment of MDSCs within the lungs. Oncoimmunology 13 (1) (2024)
Huxia Wang, Yanan Tang, Meixia Wang, Jing Zhao, Caixia Ding, Xiaomin Yang, Pihua Han, Pei-Jun Liu
Low expression of MEOX2 is associated with poor survival in patients with breast cancer. Biomarkers in medicine 16 (16) (2023)
Huxia Wang, Yanan Tang, Meixia Wang, Jing Zhao, Caixia Ding, Xiaomin Yang, Pihua Han, Pei-Jun Liu
Low expression of MEOX2 is associated with poor survival in patients with breast cancer. Biomarkers in medicine 16 (16) (2023)
Huxia Wang, Yanan Tang, Meixia Wang, Jing Zhao, Caixia Ding, Xiaomin Yang, Pihua Han, Pei-Jun Liu
Low expression of MEOX2 is associated with poor survival in patients with breast cancer. Biomarkers in medicine (2023)
Huxia Wang, Yanan Tang, Meixia Wang, Jing Zhao, Caixia Ding, Xiaomin Yang, Pihua Han, Pei-Jun Liu
Low expression of MEOX2 is associated with poor survival in patients with breast cancer. Biomarkers in medicine 16 (16) (2023)
Huxia Wang, Yanan Tang, Meixia Wang, Jing Zhao, Caixia Ding, Xiaomin Yang, Pihua Han, Pei-Jun Liu
Low expression of MEOX2 is associated with poor survival in patients with breast cancer. Biomarkers in medicine 16 (16) (2023)
Bo Wang, Zheyong Liang, Tan Tan, Miao Zhang, Yina Jiang, Yangyang Shang, Xiaoqian Gao, Shaoran Song, Ruiqi Wang, He Chen, Jie Liu, Juan Li, Yu Ren, Pei-Jun Liu
CRB3 navigates Rab11 trafficking vesicles to promote γTuRC assembly during ciliogenesis. eLife 12 (2023)
Qi Tian, Huan Gao, Yan Zhou, Lizhe Zhu, Jiao Yang, Bo Wang, Pei-Jun Liu, Jin Yang
RICH1 inhibits breast cancer stem cell traits through activating kinases cascade of Hippo signaling by competing with Merlin for binding to Amot-p80. Cell death & disease 13 (1) (2022)
Xinyan Jiao, Bo Wang, Lu Yang, Qingbin Zhao, Miao Zhang, Xiaoxu Liu, Can Zhou, Ruiqi Wang, He Chen, Jichang Wang, Yu Ren, Pei-Jun Liu
FMNL2 suppresses cell migration and invasion of breast cancer: a reduction of cytoplasmic p27 via RhoA/LIMK/Cofilin pathway. Cell death discovery 8 (1) (2022)
Lu Yang, Bo Wang, Xinyan Jiao, Can Zhou, Su Chen, Xiaoqian Gao, Wei Sun, Shaoran Song, Juan Li, Jie Liu, Yaochun Wang, Pei-Jun Liu
TAZ maintains telomere length in TNBC cells by mediating Rad51C expression. Breast cancer research : BCR 23 (1) (2021)
Zhe Zhi, Zhenlin Ouyang, Yibo Ren, Ying Cheng, Pei-Jun Liu, Yurong Wen, Yongping Shao
Non-canonical phosphorylation of Bmf by p38 MAPK promotes its apoptotic activity in anoikis. Cell death and differentiation (2021)
Bo Wang, Zheyong Liang, Pei-Jun Liu
Functional aspects of primary cilium in signaling, assembly and microenvironment in cancer. Journal of cellular physiology 236 (5) (2020)
Yi Miao, Fang Cao, Pingping Li, Pei-Jun Liu
DNA methylation of Hugl-2 is a prognostic biomarker in kidney renal clear cell carcinoma. Clinical and experimental pharmacology & physiology (2020)
Jie Liu, Juan Li, He Chen, Ruiqi Wang, Pingping Li, Yi Miao, Pei-Jun Liu
Metformin suppresses proliferation and invasion of drug-resistant breast cancer cells by activation of the Hippo pathway. Journal of cellular and molecular medicine 24 (10) (2020)
Shaoran Song, Bixia Tian, Miao Zhang, Xiaoqian Gao, Liu Jie, Pei-Jun Liu, Juan Li
Diagnostic and prognostic value of thymidylate synthase expression in breast cancer. Clinical and experimental pharmacology & physiology 48 (2) (2020)
Pei-Jun Liu, Xuefei Feng, Canyu Li, Jie Liu, Pingping Li, Ruiqi Wang, He Chen, Peijun Liu
Downregulation of WW domain-containing oxidoreductase leads to tamoxifen-resistance by the inactivation of Hippo signaling. Experimental biology and medicine (Maywood, N.J.) 244 (12) (2019)
Pingping Li, Jie Liu, Juan Li, Pei-Jun Liu
DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinoma. Molecular biology reports 46 (4) (2019)
Jie Liu, Pingping Li, Ruiqi Wang, Juan Li, Miao Zhang, Zhangjun Song, Pei-Jun Liu
High expression of DLG3 is associated with decreased survival from breast cancer. Clinical and experimental pharmacology & physiology 46 (10) (2019)
Jiao Yang, Xiaoman Zhang, Zheling Chen, Yanwei Shen, Fan Wang, Yaochun Wang, Yu Liu, Pei-Jun Liu, Jin Yang
Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer. Cell death & disease 10 (3) (2019)
Pingping Li, Can Zhou, Yu Yan, Juan Li, Jie Liu, Yan Zhang, Pei-Jun Liu
Crumbs protein homolog 3 (CRB3) expression is associated with oestrogen and progesterone receptor positivity in breast cancer. Clinical and experimental pharmacology & physiology 46 (9) (2019)
Jie Liu, Juan Li, Pingping Li, Yina Jiang, He Chen, Ruiqi Wang, Fang Cao, Pei-Jun Liu
DLG5 suppresses breast cancer stem cell-like characteristics to restore tamoxifen sensitivity by inhibiting TAZ expression. Journal of cellular and molecular medicine 23 (1) (2018)
Pingping Li, Chen Feng, He Chen, Yina Jiang, Fang Cao, Jie Liu, Pei-Jun Liu
Elevated CRB3 expression suppresses breast cancer stemness by inhibiting β-catenin signalling to restore tamoxifen sensitivity. Journal of cellular and molecular medicine 22 (7) (2018)
Zhe-Ling Chen, Jiao Yang, Yan-Wei Shen, Shu-Ting Li, Xin Wang, Meng Lv, Bi-Yuan Wang, Pan Li, Wen Zhao, Rui-Yue Qiu, Yu Liu, Pei-Jun Liu, Jin Yang
AmotP130 regulates Rho GTPase and decreases breast cancer cell mobility. Journal of cellular and molecular medicine 22 (4) (2018)
Pei-Jun Liu, Y Wang, X Mao, Y Jiang, J Liu, J Li, J Wang, R Wang, J She, J Zhang, J Yang, Y Liu, P Liu
CRB3 downregulation confers breast cancer stem cell traits through TAZ/β-catenin. Oncogenesis 6 (4) (2017)
Xiaona Mao, Pingping Li, Yaochun Wang, Zheyong Liang, Jie Liu, Juan Li, Yina Jiang, Gang Bao, Lei Li, Bofeng Zhu, Yu Ren, Xinhan Zhao, Jianmin Zhang, Yu Liu, Jin Yang, Pei-Jun Liu
CRB3 regulates contact inhibition by activating the Hippo pathway in mammary epithelial cells. Cell death & disease 8 (1) (2017)